NCT00596206 - Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis | Biotech Hunter

Enrollment

124

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Arthritis, Rheumatoid

Interventions

DRUG

leflunomide

20 or 100 mg per os, Film coated tablet, for 3 days + matching placebo, then 20 mg once daily for 3 months

Trial Locations (5)

Sanofi-Aventis Administrative Office, Prague

Sanofi-Aventis Administrative Office, Milan

Sanofi-Aventis Administrative Office, Porto Salvo

Sanofi-Aventis Administrative Office, Bucharest

Sanofi-Aventis Administrative Office, Seoul